[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Acadia Pharmaceutica (ACAD)

Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stock Indexes Finish Lower as Chipmakers Sell Off

The S&P 500 Index ($SPX ) (SPY ) on Friday closed down -0.05%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.09%. September...

SNDK : 1,745.00 (-14.13%)
STX : 820.16 (-10.38%)
WDC : 539.00 (-9.92%)
SPY : 744.78 (-0.13%)
ADSK : 207.48 (+3.86%)
MU : 975.56 (-5.49%)
QMCO : 10.16 (-7.04%)
NUTX : 196.53 (+3.05%)
QQQ : 712.60 (-1.73%)
FTNT : 156.25 (-1.72%)
NOW : 106.32 (+0.49%)
ADBE : 219.72 (+4.14%)
Stock Indexes Slip as Chipmakers Retreat

The S&P 500 Index ($SPX ) (SPY ) today is down -0.07%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.75%. September E-mini S&P futures...

AMAT : 603.04 (-7.35%)
AVGO : 360.45 (-2.41%)
SNDK : 1,745.00 (-14.13%)
INTU : 275.35 (+3.10%)
DDOG : 260.36 (-1.56%)
TXN : 293.08 (-1.79%)
$IUXX : 29,329.21 (unch)
ASML : 1,769.32 (-4.00%)
ZNU26 : 109-190 (+0.01%)
MSFT : 390.49 (+1.62%)
ESU26 : 7,565.75 (+0.05%)
STX : 820.16 (-10.38%)
Stocks Pressured by Weakness in Chipmakers

The S&P 500 Index ($SPX ) (SPY ) today is down -0.54%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.42%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.38%. September E-mini S&P futures...

AMAT : 603.04 (-7.35%)
SNDK : 1,745.00 (-14.13%)
INTU : 275.35 (+3.10%)
DDOG : 260.36 (-1.56%)
TXN : 293.08 (-1.79%)
$IUXX : 29,329.21 (unch)
ASML : 1,769.32 (-4.00%)
ZNU26 : 109-190 (+0.01%)
ESU26 : 7,565.75 (+0.05%)
STX : 820.16 (-10.38%)
WDC : 539.00 (-9.92%)
LRCX : 351.41 (-10.19%)
DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP

-- European Commission decision expected in the coming months -- If approved, DAYBU ® would become the first treatment for neurobehavioral symptoms...

ACAD : 25.97 (+3.06%)
ACADIA Pharmaceuticals Spotlights Alzheimer’s Psychosis Pipeline, NUPLAZID and DAYBUE Growth

ACADIA Pharmaceuticals (NASDAQ:ACAD) executives used an RBC Capital Markets investor session to outline the company’s clinical rationale for remlifanserin in Alzheimer’s disease psychosis, provide...

ACAD : 25.97 (+3.06%)
ACADIA Pharmaceuticals Targets $1B Brand Opportunity as Key Neuropsychiatry Data Looms

ACADIA Pharmaceuticals (NASDAQ:ACAD) executives said the company is focused on expanding its two commercial brands while preparing for several clinical data readouts in neuropsychiatric disorders, according...

ACAD : 25.97 (+3.06%)
Acadia: Q1 Earnings Snapshot

Acadia: Q1 Earnings Snapshot

ACAD : 25.97 (+3.06%)
Acadia Pharmaceuticals Reports First Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance

- First quarter DAYBUE ® GAAP net sales of $101 million, up 20% year-over-year; successful launch of DAYBUE STIX underway - First quarter...

ACAD : 25.97 (+3.06%)
Acadia Pharmaceuticals Reports Tuesday With Rett Syndrome Revenue Still Under the Microscope

Barchart Research What to Expect from ACAD Earnings ACAD Generated May 5, 2026 Current Price $22.35 EPS Estimate $$0.04 Consensus Rating Moderate Buy Average Move 7.83% Acadia Pharmaceuticals Reports Tuesday...

ACAD : 25.97 (+3.06%)
Acadia Pharmaceuticals Announces Planned Year-End Retirement of Elizabeth H.Z. Thompson, Ph.D., Head of Research and Development, Following a Distinguished Career

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the planned retirement of Elizabeth H.Z. Thompson, Ph.D., Head of Research and Development. Dr. Thompson has decided to retire for personal reasons...

ACAD : 25.97 (+3.06%)

Barchart Exclusives

The Microsoft Stock Outlook Remains Upbeat Despite Layoffs
Microsoft has become a big beneficiary of the AI boom. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.